| Patent | Date |
|---|
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole Negative Allosteric Modulators Of Nr2b
App 20220274925 - ANDERSON; David R. ; et al. | 2022-09-01 |
Thienopyrimidinone Nmda Receptor Modulators And Uses Thereof
App 20220047600 - Anderson; David R. ; et al. | 2022-02-17 |
Heteroaromatic NMDA receptor modulators and uses thereof
Grant 11,236,104 - Anderson , et al. February 1, 2 | 2022-02-01 |
Thienopyrimidinone Nmda Receptor Modulators And Uses Thereof
App 20220016117 - Anderson; David R. ; et al. | 2022-01-20 |
Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
Grant 11,116,749 - Anderson , et al. September 14, 2 | 2021-09-14 |
Heteroaromatic Nmda Receptor Modulators And Uses Thereof
App 20210107916 - Anderson; David R. ; et al. | 2021-04-15 |
Thienopyrimidinone NMDA receptor modulators and uses thereof
Grant 10,973,825 - Anderson , et al. April 13, 2 | 2021-04-13 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole Negative Allosteric Modulators Of Nr2b
App 20200369610 - ANDERSON; David R. ; et al. | 2020-11-26 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B
Grant 10,781,174 - Anderson , et al. Sept | 2020-09-22 |
Heteroaromatic NMDA receptor modulators and uses thereof
Grant 10,626,122 - Anderson , et al. | 2020-04-21 |
Thienopyrimidinone NMDA receptor modulators and uses thereof
Grant 10,500,205 - Anderson , et al. Dec | 2019-12-10 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole Negative Allosteric Modulators Of Nr2b
App 20190152912 - ANDERSON; David R. ; et al. | 2019-05-23 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of NR2B
Grant 10,239,835 - Anderson , et al. | 2019-03-26 |
Selective Octahydro-cyclopenta[c]pyrrole Negative Modulators Of Nr2b
App 20180325868 - Anderson; David R. ; et al. | 2018-11-15 |
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
Grant 10,052,306 - Anderson , et al. August 21, 2 | 2018-08-21 |
N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole Negative Allosteric Modulators Of Nr2b
App 20180111902 - ANDERSON; David R. ; et al. | 2018-04-26 |
Selective Octahydro-cyclopenta[c] Pyrrole Negative Modulators Of Nr2b
App 20170071906 - Anderson; David R. ; et al. | 2017-03-16 |
Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
Grant 9,540,324 - Anderson , et al. January 10, 2 | 2017-01-10 |
Selective Octahydro-cyclopenta[c] Pyrrole Negative Modulators Of Nr2b
App 20150225342 - Anderson; David R. ; et al. | 2015-08-13 |
Imidazole derivatives
Grant 7,078,529 - Sanner , et al. July 18, 2 | 2006-07-18 |
Imidazole derivatives
App 20060149066 - Sanner; Mark A. ; et al. | 2006-07-06 |
NMDA NR2B antagonists for treatment
Grant 7,019,016 - Chenard , et al. March 28, 2 | 2006-03-28 |
NMDA NR2B antagonists for treatment
Grant 6,958,351 - Chenard , et al. October 25, 2 | 2005-10-25 |
PDE 10 cell-based assay and sequences
App 20050026236 - James, Larry C. ; et al. | 2005-02-03 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
Grant 6,821,985 - Chenard , et al. November 23, 2 | 2004-11-23 |
Imidazole derivatives
App 20040192750 - Sanner, Mark A. ; et al. | 2004-09-30 |
NMDA NR2B antagonists for treatment
App 20040192763 - Chenard, Bertrand L. ; et al. | 2004-09-30 |
Therapeutic use of selective PDE10 inhibitors
App 20040162294 - Lebel, Lorraine A. ; et al. | 2004-08-19 |
Therapeutic use of selective PDE10 inhibitors
App 20040162293 - Lebel, Lorraine A. ; et al. | 2004-08-19 |
Imidazole derivatives
Grant 6,756,385 - Sanner , et al. June 29, 2 | 2004-06-29 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
Grant 6,667,317 - Chenard , et al. December 23, 2 | 2003-12-23 |
Disruption of the phosphodiesterase 10 gene
App 20030121069 - Menniti, Frank S. ; et al. | 2003-06-26 |
PDE10 cell-based assay and sequences
App 20030096323 - James, Larry C. ; et al. | 2003-05-22 |
Therapeutic use of selective PDE10 inhibitors
App 20030032579 - Lebel, Lorraine A. ; et al. | 2003-02-13 |
Therapeutic use of selective PDE10 inhibitors
App 20030018047 - Lebel, Lorraine A. ; et al. | 2003-01-23 |
Therapeutic use of selective PDE10 inhibitors
App 20030008806 - Lebel, Lorraine A. ; et al. | 2003-01-09 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
App 20020123510 - Chenard, Bertrand L. ; et al. | 2002-09-05 |
Imidazole derivatives
App 20020119963 - Sanner, Mark A. ; et al. | 2002-08-29 |
Prophylactic use of N-methyl-D-aspartate (NMDA) antagonists
App 20020072485 - Chenard, Bertrand L. ; et al. | 2002-06-13 |
NMDA NR2B antagonists for treatment
App 20020072538 - Chenard, Bertrand L. ; et al. | 2002-06-13 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
App 20020045656 - Chenard, Bertrand L. ; et al. | 2002-04-18 |
Methods Of Adminstering An Ampa Receptor Antagonist To Treat Dyskinesias Associated With Dopamine Agonist Therapy
App 20010034345 - GREENAMYRE, J.TIMOTHY ; et al. | 2001-10-25 |
Method Of Treating Acute, Chronic And/or Neuropathic Pain
App 20010007872 - MENNITI, FRANK S. ; et al. | 2001-07-12 |
Combinations for the treatment of parkinsonism containing selective NMDA antagonists
Grant 6,258,827 - Chenard , et al. July 10, 2 | 2001-07-10 |
Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
Grant 6,136,812 - Chenard , et al. October 24, 2 | 2000-10-24 |
| 